Commentary Regarding the Results of the <scp>PREVeNT</scp> and <scp>EPISTOP</scp> Trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Commentary Regarding the Results of the PREVeNT and EPISTOP Trials

Published:2023-11-28 Issue:1 Volume:95 Page:12-14
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Annals of Neurology

Author:

Jóźwiak Sergiusz¹^ORCID,Kotulska Katarzyna²^ORCID,Bebin E. Martina³^ORCID,Krueger Darcy A.⁴^ORCID

Affiliation:

1. Research Department The Children's Memorial Health Institute Warsaw Poland

2. Department of Neurology and Epileptology The Children's Memorial Health Institute Warsaw Poland

3. Department of Neurology University of Alabama at Birmingham Birmingham Alabama USA

4. Department of Neurology Cincinnati Children's Hospital Medical Center Cincinnati Ohio USA

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ana.26829

Reference8 articles.

1. Preventing epilepsy using vigabatrin in tuberous sclerosis complex infants (PREVeNT trial);Bebin M;Ann Neurol,2023

2. Prevention of Epilepsy in Infants with Tuberous Sclerosis Complex in the EPISTOP Trial

3. Scalp EEG spikes predict impending epilepsy in TSC infants: A longitudinal observational study

4. Antiepileptic treatment before the onset of seizures reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complex

5. Influence of seizures on early development in tuberous sclerosis complex

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP